These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 20708050
1. Selectively targeting estrogen receptors for cancer treatment. Shanle EK, Xu W. Adv Drug Deliv Rev; 2010 Oct 30; 62(13):1265-76. PubMed ID: 20708050 [Abstract] [Full Text] [Related]
4. Lead Optimization of Benzoxepin-Type Selective Estrogen Receptor (ER) Modulators and Downregulators with Subtype-Specific ERα and ERβ Activity. O'Boyle NM, Barrett I, Greene LM, Carr M, Fayne D, Twamley B, Knox AJS, Keely NO, Zisterer DM, Meegan MJ. J Med Chem; 2018 Jan 25; 61(2):514-534. PubMed ID: 28426931 [Abstract] [Full Text] [Related]
5. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands. Shanle EK, Hawse JR, Xu W. Biochem Pharmacol; 2011 Dec 15; 82(12):1940-9. PubMed ID: 21924251 [Abstract] [Full Text] [Related]
8. Discovery of a multi-target compound for estrogen receptor-positive (ER+) breast cancer: Involvement of aromatase and ERs. Almeida CF, Teixeira N, Oliveira A, Augusto TV, Correia-da-Silva G, Ramos MJ, Fernandes PA, Amaral C. Biochimie; 2021 Feb 15; 181():65-76. PubMed ID: 33278557 [Abstract] [Full Text] [Related]
9. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex. Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC. Int J Oncol; 2005 Aug 15; 27(2):327-35. PubMed ID: 16010412 [Abstract] [Full Text] [Related]
10. Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists. Evers NM, van den Berg JH, Wang S, Melchers D, Houtman R, de Haan LH, Ederveen AG, Groten JP, Rietjens IM. J Steroid Biochem Mol Biol; 2014 Sep 15; 143():376-85. PubMed ID: 24923734 [Abstract] [Full Text] [Related]
12. Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor. Wang Z, Yang Y, Zheng X, Zhang T, Huang W, Yan D, Zhang W, Wang X, Shen Z. J Pharm Pharmacol; 2018 Jul 15; 70(7):910-918. PubMed ID: 29582419 [Abstract] [Full Text] [Related]
18. Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity. Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GR. J Med Chem; 2007 May 31; 50(11):2682-92. PubMed ID: 17489582 [Abstract] [Full Text] [Related]
19. Estrogen receptors and their downstream targets in cancer. Ikeda K, Inoue S. Arch Histol Cytol; 2004 Dec 31; 67(5):435-42. PubMed ID: 15781984 [Abstract] [Full Text] [Related]
20. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer. Chan KK, Leung TH, Chan DW, Wei N, Lau GT, Liu SS, Siu MK, Ngan HY. J Endocrinol; 2014 May 31; 221(2):325-36. PubMed ID: 24819599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]